Data to be collected | Day 1: Baseline (within 24Â hours of admission) | Day 2: Interim | Day 3: Enrollment termination (within 24Â hours)* |
---|---|---|---|
Continuous interface pressure | Yes | Yes | Yes |
Clinical head-to-toe skin assessment | Yes | No | Yes |
Braden Scale | Yes | No | Yes |
Level of bed mobility | Yes | No | Yes |
Charlson comorbidity index | Yes | No | No |
Complete blood count (CBC) | Yes | No | No |
Pre-albumin | Yes | No | No |
Albumin | Yes | No | No |
Creatinine | Yes | No | No |
Liver function test results (alkaline phosphatase; aspartate aminotransferase (AST)) | Yes | No | No |
C reactive protein (CRP) | Yes | No | No |
Glycosylated hemoglobin | Yes | No | No |
Body mass index (BMI) | Yes | No | No |
Reason for admission/diagnoses | Yes | No | No |
Bladder management | Yes | No | No |
Bowel management | Yes | No | No |
History of cancer and treatment | Yes | No | No |
History of cardiovascular disease | Yes | No | No |
History of renal failure | Yes | No | No |
Use of immunosuppressive medications | Yes | No | No |
Pressure ulcer history | Yes | No | No |
Smoking history | Yes | No | No |
Illicit drug use | Yes | No | No |
Demographics (that is, sex, date of birth, race) | Yes | No | No |
Perceptions of healthcare providers of patients in the treatment group** | No | No | No |
Perceptions of patients (and/or their family members) in the treatment group | No | No | Yes |
Pressure ulcer prevention and treatment methods | No | No | Yes |